DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
Display Options:
Drug type
Therapeutic Area
Route of administration
Mechanism of Action
Indication
Status
Total:
6532
FISOGATINIB
1
Small molecule
Investigational
Unknown
Unknown
Carcinoma, Hepatocellular
Unknown
FISOGATINIB
×
Maximum Phase:
1
First Approval:
None
UNII:
5Q7R99CKV2
Molecule Type:
Small molecule
Molecular Formula:
C24H24Cl2N4O4
Molecular Weight:
503.39
AlogP:
4.49
PSA:
94.6
HBD:
2.0
HBA:
#RotB:
7.0
Source:
RXDX-105
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
RXDX-105
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
AZELOPRAZOLE SODIUM
1
Small molecule
Investigational
Unknown
Unknown
Gastroesophageal Reflux
Unknown
AZELOPRAZOLE SODIUM
×
Maximum Phase:
1
First Approval:
None
UNII:
KDJ60607ON
Molecule Type:
Small molecule
Molecular Formula:
C22H26N3NaO4S
Molecular Weight:
451.52
AlogP:
3.66
PSA:
86.33
HBD:
1.0
HBA:
#RotB:
6.0
Source:
D-FLUOROMETHYLTYROSINE
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
D-FLUOROMETHYLTYROSINE
×
Maximum Phase:
1
First Approval:
None
UNII:
GSM7N3U4J8
Molecule Type:
Small molecule
Molecular Formula:
C10H12FNO3
Molecular Weight:
213.21
AlogP:
0.95
PSA:
72.55
HBD:
2.0
HBA:
#RotB:
5.0
Source:
PF-03882845
1
Small molecule
Investigational
Unknown
Unknown
Diabetes Mellitus, Type 2; Diabetic Nephropathies
Mineralocorticoid receptor antagonist
PF-03882845
×
Maximum Phase:
1
First Approval:
None
UNII:
34ZKU73FU3
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
XANOMELINE
1
Small molecule
Investigational
Unknown
Unknown
Schizophrenia
Muscarinic acetylcholine receptor M1 agonist
XANOMELINE
×
Maximum Phase:
1
First Approval:
None
UNII:
9ORI6L73CJ
Molecule Type:
Small molecule
Molecular Formula:
C14H23N3OS
Molecular Weight:
281.43
AlogP:
3.22
PSA:
38.25
HBD:
0.0
HBA:
#RotB:
7.0
Source:
CHLORCYCLIZINE
1
Small molecule
Investigational
Unknown
Unknown
Hypersensitivity
Unknown
CHLORCYCLIZINE
×
Maximum Phase:
1
First Approval:
None
UNII:
M26C4IP44P
Molecule Type:
Small molecule
Molecular Formula:
C18H21ClN2
Molecular Weight:
300.83
AlogP:
3.68
PSA:
6.48
HBD:
0.0
HBA:
#RotB:
3.0
Source:
AM-461
1
Small molecule
Investigational
Unknown
Unknown
Unknown
G protein-coupled receptor 44 antagonist
AM-461
×
Maximum Phase:
1
First Approval:
None
UNII:
JCG5PW623C
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
FEDOVAPAGON
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
FEDOVAPAGON
×
Maximum Phase:
1
First Approval:
None
UNII:
VX2GBO4I0V
Molecule Type:
Small molecule
Molecular Formula:
C27H34N4O3
Molecular Weight:
462.59
AlogP:
3.74
PSA:
72.96
HBD:
1.0
HBA:
#RotB:
4.0
Source:
CI-988
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Cholecystokinin B receptor antagonist
CI-988
×
Maximum Phase:
1
First Approval:
None
UNII:
2637PDX9SI
Molecule Type:
Small molecule
Molecular Formula:
C35H42N4O6
Molecular Weight:
614.74
AlogP:
4.86
PSA:
149.62
HBD:
5.0
HBA:
#RotB:
12.0
Source:
MK-8245
1
Small molecule
Investigational
Unknown
Unknown
Diabetes Mellitus, Type 2
Unknown
MK-8245
×
Maximum Phase:
1
First Approval:
None
UNII:
537E7QE8LX
Molecule Type:
Small molecule
Molecular Formula:
C17H16BrFN6O4
Molecular Weight:
467.26
AlogP:
2.36
PSA:
119.4
HBD:
1.0
HBA:
#RotB:
6.0
Source:
EM-1421
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
EM-1421
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
AZELOPRAZOLE
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
AZELOPRAZOLE
×
Maximum Phase:
1
First Approval:
None
UNII:
MIR2G6L61B
Molecule Type:
Small molecule
Molecular Formula:
C22H27N3O4S
Molecular Weight:
429.54
AlogP:
3.66
PSA:
86.33
HBD:
1.0
HBA:
#RotB:
6.0
Source:
MSX-122
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
C-X-C chemokine receptor type 4 antagonist
MSX-122
×
Maximum Phase:
1
First Approval:
None
UNII:
69D634Q702
Molecule Type:
Small molecule
Molecular Formula:
C16H16N6
Molecular Weight:
292.35
AlogP:
2.49
PSA:
75.62
HBD:
2.0
HBA:
#RotB:
6.0
Source:
BMS-908662
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
BMS-908662
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
AS-602868
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Inhibitor of nuclear factor kappa B kinase beta subunit inhibitor
AS-602868
×
Maximum Phase:
1
First Approval:
None
UNII:
Y1FZ8P93E0
Molecule Type:
Small molecule
Molecular Formula:
C18H14N4O3S
Molecular Weight:
366.4
AlogP:
3.01
PSA:
84.42
HBD:
1.0
HBA:
#RotB:
4.0
Source:
CT-1578
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Macrophage colony stimulating factor receptor inhibitor
CT-1578
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
MK3207
1
Small molecule
Investigational
Unknown
Unknown
Migraine Disorders
Calcitonin gene-related peptide type 1 receptor antagonist
MK3207
×
Maximum Phase:
1
First Approval:
None
UNII:
5C44M1QYCC
Molecule Type:
Small molecule
Molecular Formula:
C31H29F2N5O3
Molecular Weight:
557.6
AlogP:
3.77
PSA:
103.43
HBD:
3.0
HBA:
#RotB:
4.0
Source:
TALOTREXIN
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
TALOTREXIN
×
Maximum Phase:
1
First Approval:
None
UNII:
A8E516A20K
Molecule Type:
Small molecule
Molecular Formula:
C27H27N9O6
Molecular Weight:
573.57
AlogP:
1.29
PSA:
248.43
HBD:
7.0
HBA:
#RotB:
12.0
Source:
TELENZEPINE
1
Small molecule
Investigational
Unknown
Unknown
Obesity
Unknown
TELENZEPINE
×
Maximum Phase:
1
First Approval:
None
UNII:
0990EG3K10
Molecule Type:
Small molecule
Molecular Formula:
C19H22N4O2S
Molecular Weight:
370.48
AlogP:
2.53
PSA:
55.89
HBD:
1.0
HBA:
#RotB:
2.0
Source:
BMS-214662
1
Small molecule
Investigational
Unknown
Unknown
Anemia, Refractory, with Excess of Blasts; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Promyelocytic, Acute; Neoplasms; Precursor Cell Lymphoblastic Leukemia-Lymphoma
Unknown
BMS-214662
×
Maximum Phase:
1
First Approval:
None
UNII:
L2U9GFD244
Molecule Type:
Small molecule
Molecular Formula:
C25H23N5O2S2
Molecular Weight:
489.63
AlogP:
4.17
PSA:
93.09
HBD:
1.0
HBA:
#RotB:
6.0
Source:
.ALPHA.-PYRROLIDINONONANOPHENONE
1
Small molecule
Investigational
Unknown
Unknown
Melanoma
Unknown
.ALPHA.-PYRROLIDINONONANOPHENONE
×
Maximum Phase:
1
First Approval:
None
UNII:
S3FKL8RY1D
Molecule Type:
Small molecule
Molecular Formula:
C19H29NO
Molecular Weight:
287.45
AlogP:
4.69
PSA:
20.31
HBD:
0.0
HBA:
#RotB:
9.0
Source:
GSK-690693
1
Small molecule
Investigational
Unknown
Unknown
Neoplasms
cAMP-dependent protein kinase (PKA) inhibitor
GSK-690693
×
Maximum Phase:
1
First Approval:
None
UNII:
GWH480321B
Molecule Type:
Small molecule
Molecular Formula:
C21H27N7O3
Molecular Weight:
425.49
AlogP:
1.58
PSA:
137.14
HBD:
3.0
HBA:
#RotB:
5.0
Source:
BISTHIANOSTAT
1
Small molecule
Investigational
Unknown
Unknown
Multiple Myeloma
Unknown
BISTHIANOSTAT
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C15H18N4O3S2
Molecular Weight:
366.47
AlogP:
2.55
PSA:
104.21
HBD:
3.0
HBA:
#RotB:
8.0
Source:
RG7185
1
Small molecule
Investigational
Unknown
Unknown
Unknown
G protein-coupled receptor 44 antagonist
RG7185
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
FK453
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Adenosine A1 receptor antagonist
FK453
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C23H25N3O2
Molecular Weight:
375.47
AlogP:
3.78
PSA:
57.84
HBD:
1.0
HBA:
#RotB:
5.0
Source:
9-ING-41
1
Small molecule
Investigational
Unknown
Unknown
Bone Neoplasms; Breast Neoplasms; Glioma; Kidney Neoplasms; Lung Neoplasms; Neoplasm Metastasis; Sarcoma; Primary Myelofibrosis
Glycogen synthase kinase-3 beta inhibitor
9-ING-41
×
Maximum Phase:
1
First Approval:
None
UNII:
ND1SOF0DLU
Molecule Type:
Small molecule
Molecular Formula:
C22H13FN2O5
Molecular Weight:
404.35
AlogP:
3.36
PSA:
82.7
HBD:
1.0
HBA:
#RotB:
2.0
Source:
CO-ZIDOCAPT
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
CO-ZIDOCAPT
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
C16H23ClN4O7S3
Molecular Weight:
515.04
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
ASTAXANTHIN
1
Small molecule
Investigational
Unknown
Unknown
Metabolic Syndrome; Diabetic Neuropathies
Unknown
ASTAXANTHIN
×
Maximum Phase:
1
First Approval:
None
UNII:
8XPW32PR7I
Molecule Type:
Small molecule
Molecular Formula:
C40H52O4
Molecular Weight:
596.85
AlogP:
8.91
PSA:
74.6
HBD:
2.0
HBA:
#RotB:
10.0
Source:
SALVIANOLIC ACID A
1
Small molecule
Investigational
Unknown
Unknown
Diabetes Mellitus; Diabetic Neuropathies
Unknown
SALVIANOLIC ACID A
×
Maximum Phase:
1
First Approval:
None
UNII:
51622542XO
Molecule Type:
Small molecule
Molecular Formula:
C26H22O10
Molecular Weight:
494.45
AlogP:
3.34
PSA:
184.98
HBD:
7.0
HBA:
#RotB:
8.0
Source:
CFG-920
1
Small molecule
Investigational
Unknown
Unknown
Prostatic Neoplasms; Prostatic Neoplasms, Castration-Resistant
Unknown
CFG-920
×
Maximum Phase:
1
First Approval:
None
UNII:
UP0K5026VB
Molecule Type:
Small molecule
Molecular Formula:
C14H13ClN4O
Molecular Weight:
288.74
AlogP:
2.89
PSA:
49.33
HBD:
0.0
HBA:
#RotB:
2.0
Source:
CH5132799
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
CH5132799
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
XL-019
1
Small molecule
Investigational
Unknown
Unknown
Polycythemia Vera; Primary Myelofibrosis; Thrombocythemia, Essential
Tyrosine-protein kinase JAK2 inhibitor
XL-019
×
Maximum Phase:
1
First Approval:
None
UNII:
4L1AM42NVA
Molecule Type:
Small molecule
Molecular Formula:
C25H28N6O2
Molecular Weight:
444.54
AlogP:
3.41
PSA:
91.41
HBD:
3.0
HBA:
#RotB:
6.0
Source:
PKI-166
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Epidermal growth factor receptor erbB1 inhibitor
PKI-166
×
Maximum Phase:
1
First Approval:
None
UNII:
9RIE5HW38P
Molecule Type:
Small molecule
Molecular Formula:
C20H18N4O
Molecular Weight:
330.39
AlogP:
4.5
PSA:
73.83
HBD:
3.0
HBA:
#RotB:
4.0
Source:
DIINDOLYLMETHANE
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
DIINDOLYLMETHANE
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
1
2
…
76
77
78
79
80
81
82
…
186
187
Next »
Download Option
Close
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA